超重可能是急性高山病的危险因素:一项Meta分析

熊娟; 鹿辉; 王荣; 贾正平

doi:10.3969/j.issn.1006-0111.2018.05.011

超重可能是急性高山病的危险因素:一项Meta分析

doi: 10.3969/j.issn.1006-0111.2018.05.011

兰州总医院药剂科, 甘肃兰州 730050

基金项目: 全军后勤科研项目（CWH17J012）；国家自然科学基金资助（81401552）

Overweight might be a risk factor of acute mountain sickness: a Meta-analysis

Department of Pharmacy, Lanzhou General Hospital, Lanzhou 730050, China

摘要: 目的超重也许是急性高山病（acute mountain sickness，AMS）的危险因素，但仍存在很多争议。因此，进行Meta分析研究超重在AMS发生中的作用。方法利用电子数据库系统检索研究超重与AMS相关性的文献（截至2018年2月28日）。利用Mantel-Haenszel随机效应模型进行数据整合。纳入文献的异质性由I²的值表示。以P<0.05为具有显著性差异。用Revman 5.0软件处理和分析数据，结果以95%置信区间森林图的形式表示。结果纳入研究的566名超重志愿者中有300名患AMS（53%），而1 006名非超重志愿者中只有338名患AMS（34%），超重志愿者患AMS的危险比率（risk ratio，RR）为2.02（95% CI 1.08~3.76，Z=2.21，P=0.03）。结果表明超重是AMS发生的一项危险因素。结论虽然需要进一步深入的研究来确认超重在AMS发生中的作用，但根据有限的研究提示，超重也许是AMS发生的危险因素。因此，超重个体在进入高海拔地区前，应当做好充分的预防措施来避免AMS的发生。
- 超重 /
- 急性高山病 /
- 荟萃分析
Abstract: Objective Overweight might be a risk factor of acute mountain sickness (AMS) but its efficacy on developing AMS remained controversial. To study the role of overweight in AMS by a Meta-analysis. Methods A comprehensive literature search (last update, February 28th 2018) was carried out by searching electronic databases for full texts of studies which compared incidence of AMS in overweight with non-overweight individuals. The primary outcome measure for this meta-analysis was the incidence of AMS. Mantel-Haenszel random effect model was used to aggregate data. Heterogeneity of included trials was interpreted by I² values. A α level of 0.05 was used as the level of significance. The results were reported in a forest plot with 95% CI. Revman 5.0 software provided by the Cochrane Collaboration was used for data processing and analysis. Results AMS occurred in 300 of 566 (53%) in overweight individuals and in 338 of 1 006 (34%) in non-overweight individuals. Compared with non-overweight individuals and independent of the baseline risk ratio (RR), the combined RR of developing AMS in overweight individuals was 2.02 (95% CI 1.08 to 3.76, Z=2.21, P=0.03). It was suggested that obese was a risk factor for developing AMS. The five included studies had high heterogeneity (I²=94%). Conclusion Although further in-depth studies were needed to confirm the function of overweight in the development of AMS, according to a limited number of studies, overweight might be a risk factor of AMS. Therefore, overweight individuals should be provided adequate prophylaxis against AMS before ascent to high altitude.
- overweight /
- acute mountain sickness /
- Meta-analysis

[1]	BARTSCH P,SWENSON ER. Clinical practice:acute high-altitude illnesses[J].N Engl J Med, 2013, 368(24):2294-2302.
[2]	SCHNEIDER M, BERNASCH D, WEYMANN J, et al. Acute mountain sickness:influence of susceptibility, preexposure, and ascent rate[J].Med Sci Sports Exerc, 2002, 34(12):1886-1891.
[3]	FIORE DC, HALL S,SHOJA P. Altitude illness:risk factors, prevention, presentation, and treatment[J].Am Fam Physician, 2010, 82(9):1103-1110.
[4]	KAYSER B,VERGES S. Hypoxia, energy balance and obesity:from pathophysiological mechanisms to new treatment strategies[J].Obes Rev, 2013, 14(7):579-592.
[5]	ROACH RC, HOUSTON CS, HONIGMAN B, et al. How well do older persons tolerate moderate altitude[J].West J Med, 1995, 162(1):32-36.
[6]	RI-LI G, CHASE PJ, WITKOWSKI S, et al. Obesity:associations with acute mountain sickness[J].Ann Intern Med, 2003, 139(4):253-257.
[7]	HIRATA K, MASUYAMA S,SAITO A. Obesity as risk factor for acute mountain sickness[J].Lancet,1989,2(8670):1040-1041.
[8]	MCDEVITT M, MCINTOSH SE, RODWAY G, et al. Risk determinants of acute mountain sickness in trekkers in the Nepali Himalaya:a 24-year follow-up[J].Wilderness Environ Med, 2014, 25(2):152-159.
[9]	WU TY, DING SQ, LIU JL, et al. Who should not go high:chronic disease and work at altitude during construction of the Qinghai-Tibet railroad[J].High Alt Med Biol, 2007, 8(2):88-107.
[10]	YANG B, SUN ZJ, CAO F, et al. Obesity is a risk factor for acute mountain sickness:a prospective study in Tibet railway construction workers on Tibetan plateau[J].Eur Rev Med Pharmacol Sci, 2015, 19(1):119-122.
[11]	GAILLARD S, DELLASANTA P, LOUTAN L, et al. Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal:a 12-year follow-up[J].High Alt Med Biol, 2004, 5(4):410-419.
[12]	WAGNER DR, FARGO JD, PARKER D, et al. Variables contributing to acute mountain sickness on the summit of Mt Whitney[J].Wilderness Environ Med, 2006, 17(4):221-228.
[13]	HIGGINS JP,THOMPSON SG. Quantifying heterogeneity in a meta-analysis[J].Stat Med, 2002, 21(11):1539-1558.
[14]	GERTSCH JH, LIPMAN GS, HOLCK PS, et al. Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache:the Headache Evaluation at Altitude Trial (HEAT)[J].Wilderness Environ Med, 2010, 21(3):236-243.
[15]	GERTSCH JH, CORBETT B, HOLCK PS, et al. Altitude sickness in climbers and efficacy of NSAIDs trial (ASCENT):randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness[J].Wilderness Environ Med, 2012, 23(4):307-315.
[16]	LIPMAN GS, KANAAN NC, HOLCK PS, et al. Ibuprofen prevents altitude illness:a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories[J].Ann Emerg Med, 2012, 59(6):484-490.
[17]	HSU TY, WENG YM, CHIU YH, et al. Rate of ascent and acute mountain sickness at high altitude[J].Clin J Sport Med, 2015, 25(2):95-104.
[18]	WANG SH, CHEN YC, KAO WF, et al. Epidemiology of acute mountain sickness on Jade Mountain, Taiwan:an annual prospective observational study[J].High Alt Med Biol, 2010, 11(1):43-49.

[1]	葛佳佳, 张莹莹. β-内酰胺类联合大环内酯类药物治疗儿童社区获得性肺炎的有效性与安全性的Meta分析 . 药学实践与服务, 2021, 39(3): 274-279. doi: 10.12206/j.issn.1006-0111.202007077
[2]	岑菁, 吕珊, 唐敏. 头孢他啶/阿维巴坦治疗碳青霉烯类耐药肠杆菌感染疗效和安全性的Meta分析 . 药学实践与服务, 2021, 39(4): 373-378. doi: 10.12206/j.issn.1006-0111.202007011
[3]	廖小兰, 汪滢, 黄爱文, 郭秀强, 赖彦岚, 宋洪涛. 安罗替尼在治疗癌症患者中高血压的发生率和发生风险：一项系统评价和Meta分析 . 药学实践与服务, 2020, 38(6): 552-557. doi: 10.12206/j.issn.1006-0111.202008069
[4]	林莉莉, 姚囡囡, 吴珏, 刘志宏, 宋洪涛. 糠酸氟替卡松/维兰特罗复方剂治疗哮喘疗效与耐受性的Meta分析 . 药学实践与服务, 2019, 37(5): 473-480. doi: 10.3969/j.issn.1006-0111.2019.05.018
[5]	金飞虹, 陈婕, 杨文超. 银杏二萜内酯葡胺注射液治疗脑梗死的疗效及安全性的Meta分析 . 药学实践与服务, 2019, 37(1): 80-85. doi: 10.3969/j.issn.1006-0111.2019.01.019
[6]	郑丽丽, 轩辕欢, 姜倩, 范芳芳, 姚莉, 赵生俊. 比较万古霉素持续输注与间断输注引起肾毒性的荟萃分析 . 药学实践与服务, 2018, 36(2): 136-139,146. doi: 10.3969/j.issn.1006-0111.2018.02.009
[7]	白向荣, 程红勤, 张雁, 金颖. 两性霉素B膀胱冲洗治疗真菌尿的荟萃分析 . 药学实践与服务, 2018, 36(4): 379-384. doi: 10.3969/j.issn.1006-0111.2018.04.021
[8]	靳海潮, 邢方凯, 陈涛, 吕文苓. 氨柔比星用于小细胞肺癌二线治疗的荟萃分析 . 药学实践与服务, 2017, 35(1): 82-86. doi: 10.3969/j.issn.1006-0111.2017.01.021
[9]	应茵, 陆绪亮, 董威夷, 宋洪涛. 10 mg多廿烷醇与等剂量阿托伐他汀在血脂异常患者中调脂疗效比较的荟萃分析 . 药学实践与服务, 2017, 35(3): 282-288. doi: 10.3969/j.issn.1006-0111.2017.03.022
[10]	熊娟, 鹿辉, 王荣, 贾正平. 急性高山病防治研究进展 . 药学实践与服务, 2017, 35(2): 97-101. doi: 10.3969/j.issn.1006-0111.2017.02.001
[11]	陶伊琳, 黄幼明, 林惠娥. 选择性二肽基肽酶抑制剂维格列汀与关节痛/骨关节炎发病风险相关性的系统评价 . 药学实践与服务, 2016, 34(6): 540-545. doi: 10.3969/j.issn.1006-0111.2016.06.015
[12]	刘留, 费素娟. 双歧杆菌三联活菌胶囊辅助根除幽门螺杆菌感染临床疗效的荟萃分析 . 药学实践与服务, 2016, 34(4): 380-384. doi: 10.3969/j.issn.1006-0111.2016.04.025
[13]	万素馨, 黄道秋, 余蕾, 向毅, 方伟. 左氧氟沙星治疗耐多药肺结核疗效的系统评价/荟萃分析的质量评价 . 药学实践与服务, 2016, 34(6): 546-551. doi: 10.3969/j.issn.1006-0111.2016.06.016
[14]	鲍思蔚, 张誉艺, 胡燕鸣, 翟晓波, 何志高. 氨曲南与头孢他啶治疗下呼吸道感染的荟萃分析 . 药学实践与服务, 2016, 34(1): 83-85,89. doi: 10.3969/j.issn.1006-0111.2016.01.022
[15]	田怀平, 高蕙敏, 张金莲, 唐跃年. 拉莫三嗪治疗儿童及青少年失神性癫痫的系统评价 . 药学实践与服务, 2015, 33(3): 263-268. doi: 10.3969/j.issn.1006-0111.2015.03.020
[16]	林秀丽, 石鹤坤, 陈尚瑜, 陈锦珊. 复方甘草酸苷片治疗慢性湿疹的荟萃分析 . 药学实践与服务, 2015, 33(4): 380-382,384. doi: 10.3969/j.issn.1006-0111.2015.04.024
[17]	樊蓉, 任天舒, 赵庆春, 史国兵. 西药常规治疗联用通心络胶囊治疗冠心病心绞痛疗效的荟萃分析 . 药学实践与服务, 2015, 33(1): 83-87. doi: 10.3969/j.issn.1006-0111.2015.01.024
[18]	蔡和平, 王卓. 拓扑替康标准方案与周疗方案治疗小细胞肺癌的荟萃分析 . 药学实践与服务, 2014, 32(1): 23-26,30. doi: 10.3969/j.issn.1006-0111.2014.01.006
[19]	马骏, 樊鹏程, 张强, 马慧萍, 王荣, 贾正平. 预防和治疗高原病药物临床用药参考 . 药学实践与服务, 2013, 31(4): 246-250. doi: 10.3969/j.issn.1006-0111.2013.04.002
[20]	承国庆, 刘明忠, 邵伯军. 头孢曲松(罗氏芬)预防围手术期感染的荟萃分析 . 药学实践与服务, 2001, (2): 114-116,110.

点击查看大图

计量

文章访问数: 2312
HTML全文浏览量: 256
PDF下载量: 292
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

超重可能是急性高山病的危险因素:一项Meta分析

doi: 10.3969/j.issn.1006-0111.2018.05.011

Overweight might be a risk factor of acute mountain sickness: a Meta-analysis

计量

超重可能是急性高山病的危险因素:一项Meta分析

doi: 10.3969/j.issn.1006-0111.2018.05.011

兰州总医院药剂科, 甘肃兰州 730050

English Abstract

Overweight might be a risk factor of acute mountain sickness: a Meta-analysis

Department of Pharmacy, Lanzhou General Hospital, Lanzhou 730050, China

全文HTML

目录

留言板

超重可能是急性高山病的危险因素:一项Meta分析

doi: 10.3969/j.issn.1006-0111.2018.05.011

Overweight might be a risk factor of acute mountain sickness: a Meta-analysis

计量

出版历程

超重可能是急性高山病的危险因素:一项Meta分析

doi: 10.3969/j.issn.1006-0111.2018.05.011

兰州总医院药剂科, 甘肃 兰州 730050

English Abstract

Overweight might be a risk factor of acute mountain sickness: a Meta-analysis

Department of Pharmacy, Lanzhou General Hospital, Lanzhou 730050, China

全文HTML

目录

兰州总医院药剂科, 甘肃兰州 730050